October 12, 2020

Within3 CEO Lance Hill interviewed on PYMNTS.com

Within3’s CEO on how the company solves for communication that is difficult, redundant, or expensive in the changing virtual landscape of healthcare research

The entire healthcare system has gone from emergency mode to a new normal in just months after COVID-19 disrupted supply chains, customer care, communications, and even the ability to go into work, CEO Lance Hill of patient-engagement platform Within3 told PYMNTS in a recent conversation. And although the pandemic is far from over, Hill expects many of the changes will outlast the disease.

Read the entire article

Related Posts:

patient engagement decentralized trials

Within3 in Outsourcing Pharma: Trial tech can strengthen human connections

High-tech tools have long been part of the clinical trial process, but when they’re absent or used improperly, patient engagement can suffer.
how AI can help pharma teams

Within3 in PharmExec: how artificial intelligence can help pharma teams collect and analyze data

Within3 CTO, AI & Analytics Jason Smith talks to PharmExec about AI, compliance, and the patient experience.
scientific data in medical affairs

Within3 in the MSL Journal: Is AI the Key to Stronger MSL Relationships?

Within3 CEO Lance Hill and Executive Director, Medical Affairs Mike Abbadessa in the Journal of the Medical Science Liaison Society.